×


<- Back

CSL

Business / Practice Details
Business / Provider Type
Associations, Support
Services Offered
Employee Assessments
Profile
Business / Provider Profile
CSL was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994. Today, CSL comprises businesses with longstanding, specialized expertise:

- CSL Behring, a global leader in rare and serious diseases; its subsidiary CSL Plasma, which operates one of the world’s largest plasma collection networks;
- CSL Seqirus, one of the largest influenza vaccine providers in the world; and,
- CSL Vifor, a leader in iron deficiency and nephrology.

Together, our combined and robust histories are delivering a healthier today and a better tomorrow for patients and people everywhere.
Why us
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
Business Address
Global Headquarters 655 Elizabeth Street Melbourne VIC 3000 Australia,
Melbourne VIC 3000, Australia
Location Map View Map
Social Media
Website